GMMMG logo

NHS photos

NHS logo

GMMMG Consultations

 

On this page you will find proposed changes that are currently going through the GMMMG approval process. This will include consultations on proposed RAG status, updated Formulary Chapters, Pathways or other GMMMG Guidance. You will be able to comment on current proposals via the links in the table below.

Title

Information

Feedback

End date

24

FMESG - proposed actions for consultation

The following actions were proposed at the March 2018 FMESG meeting, approved in principle by GMMMG in April, and are now open for GM wide consultation. Comments are invited up until 5pm Tuesday 15th May 2018 and should be submitted here

Feedback Form

5pm Tuesday
15th May 2018

23

GM Model Framework for dermatology services

Under direction of the GM Directors of Commissioning  the GM Dermatology Group are developing the GM Model Framework for dermatology services. The group has produced a series of educational tools which will help to improve confidence of managing skin in primary care and upskill clinicians in primary care at the same time.

Included in the educational pack is:

5pm Wednesday 2nd May 2018

A GM pathway of care from primary care to tertiary care

Acne management

Eczema management

Psoriasis management

Warts management

Actinic Keratosis management

Refreshed skin chapter

2WW pathway

Emollient and steroid ladders

 

Feedback Form 23a

Feedback Form 23b

Feedback Form 23c

Feedback Form 23d

Feedback Form 23e

A number of these are now opened (see links above) for GM wide consultation in line with the GMMMG approval process. Please submit any comments using the appropriate feedback form links above, this consultation will close at 5pm Wednesday 2nd May 2018.

Industry are invited to comment on factual inaccuracy only.

22

Revised DNP and grey lists for consultation

The Greater Manchester DNP and grey lists have been revised to reflect recent NHS England guidance. Please note that the list contains items previously considered by GMMMG and not included in the NHS England list. Changes to these items are purely editorial, in order to harmonise wording throughout. The list also contains three new items to be considered for inclusion.

The revised list is now open for GM-wide consultation for 6 weeks. Industry are invited to comment on factual inaccuracies only. Following consultation the list will be taken forward to AGG for policy development. Comments are invited up until 5pm on Tuesday 22nd May 2018 and should be submitted here.

Feedback Form

5pm Tuesday
22nd May 2018

21

Ciclosporin for childhood nephrotic syndrome

On behalf of the GMMMG Pathways and Guidelines Development Subgroup, a Greater Manchester wide Shared Care Protocol for  ciclosporin for childhood nephrotic syndrome is in development. We now seek the comments of all GM NHS healthcare professionals on this draft. This consultation period is open until 5pm on 18th May 2018.

Feedback Form

5pm Friday
18th May 2018

20

Sulfasalazine for inflammatory bowel disease

On behalf of the GMMMG Pathways and Guidelines Development Subgroup, a Greater Manchester wide Shared Care Protocol for  sulfasalazine for inflammatory bowel disease is in development. We now seek the comments of all GM NHS healthcare professionals on this draft. This consultation period is open until 5pm on 18th May 2018.

Feedback Form

5pm Friday
18th May 2018

19

Domperidone for paediatric gastro-oesophageal reflux disease

On behalf of the GMMMG Pathways and Guidelines Development Subgroup, a Greater Manchester wide Shared Care Protocol for domperidone for paediatric gastro-oesophageal reflux disease  is in development. We now seek the comments of all GM NHS healthcare professionals on this draft. This consultation period is open until 5pm on 18th May 2018.

Feedback Form

5pm Friday
18th May 2018

18

Disulfiram for alcohol dependence

On behalf of the GMMMG Pathways and Guidelines Development Subgroup, a Greater Manchester wide Shared Care Protocol for disulfiram for alcohol dependence  is in development. We now seek the comments of all GM NHS healthcare professionals on this draft. This consultation period is open until 5pm on 18th May 2018.

Feedback Form

5pm Friday
18th May 2018

<< Back

Line

TERMS AND CONDITIONS    |    CONTACT US    |    ABOUT US    |    ARCHIVE

RSS Feed
 
spacer